Amitza
- Product NDC
- 72189-410
- Requested package NDC
- 72189-410-60
- 11-digit product format
- 721890410
- Labeler code
- 72189
- Product ID
- 72189-410_2c4cfec2-fedf-e007-e063-6294a90a3cf9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lubiprostone
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA209920
- Marketing category
- ANDA
- Marketing start
- 2023-01-12
- Substance
- LUBIPROSTONE
- Active strength
- 8 ug/1
- Pharmacologic classes
- Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72189-410 | 72189-410-60 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72189-410 | 72189-410-60 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209920-001 | LUBIPROSTONE | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | |
| A209920-002 | LUBIPROSTONE | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209920-001 | AB |
| A209920-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | bb7c543d1eb4… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A209920-001 | LUBIPROSTONE | 8MCG | CAPSULE / ORAL | AB | 2022-01-18 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A209920-002 | LUBIPROSTONE | 24MCG | CAPSULE / ORAL | AB | 2022-01-18 | 1c564ffb4f44… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209920-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209920-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209920-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209920-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209920-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209920-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209920-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209920-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209920-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209920-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209920-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209920-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209920-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209920-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209920-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209920-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209920-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209920-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209920-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209920-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209920-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209920-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209920-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209920-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209920-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209920-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209920-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209920-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209920-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209920-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209920-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209920-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209920-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209920-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A209920-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A209920-002 | AB | 1 | bb7c543d1eb4… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209920-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209920-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A209920-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A209920-002 | AB | 1 | 1c564ffb4f44… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amitza
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LUBIPROSTONE | 8 ug/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7662KG2R6K | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f2121338-9586-161d-e053-2995a90af908 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3b517f14-6449-952f-8aaf-98f2ec9051d0 | Product name | 3 | 20251024 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-410-60 | Amitza | 60 in 1 BOTTLE | CAPSULE, GELATIN COATED | 60 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-410-60 | EA - Each | 72189-410 | 9b8c8794-6b8d-4f7a-989c-73f848a2c720 | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lubiprostone | LUBIPROSTONE | Proficient Rx LP | 5fd683a5-87ff-42b8-a8c8-fff81625f67f | 2026-07-01 | Warnings, Adverse reactions | 209920 ANDA209920 |
| Lubiprostone | LUBIPROSTONE | American Health Packaging | 3014dd6d-9c05-479d-b79d-7a49f78a1ce5 | 2026-03-24 | Warnings, Adverse reactions | 209920 ANDA209920 |
| Amitza | LUBIPROSTONE | Direct_Rx | f2121338-9586-161d-e053-2995a90af908 | 2025-01-22 | Warnings, Adverse reactions | 209920 ANDA209920 72189-410-60 72189-410 72189041060 |
| Lubiprostone | LUBIPROSTONE | Teva Pharmaceuticals, Inc. | e17b521e-2c25-4bef-82f9-7916fa79bca4 | 2022-05-27 | Warnings, Adverse reactions | 209920 ANDA209920 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72189-410-60 | 72189041060 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (72189-410-60) | 2023-01-12 | 0000-00-00 | No | No | Current |